Healthcare Services

Omics-Based Clinical Trials Market Future Outlook Showing Expansion Toward $47.77 Billion by 2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Omics-Based Clinical Trials Market In 2026 And What Value Is Projected For 2030?

The omics-based clinical trials market has experienced strong expansion in recent years. It is anticipated to grow from $31.71 billion in 2025 to $34.49 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.8%. This historical growth can be linked to several contributing factors, including the increasing complexity of clinical trial designs, advancements in genomic and proteomic research, a rising demand for personalized therapies, the expansion of clinical research infrastructure, and growing collaboration between pharmaceutical firms and academic institutions.

The omics-based clinical trials market size is projected to experience robust expansion over the forthcoming years. This market is anticipated to reach $47.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period stems from several factors, including the increasing integration of precision medicine approaches, growing investments in data-driven clinical trials, the expanding use of AI-enabled patient recruitment, greater regulatory acceptance of omics-based endpoints, and a heightened demand for efficient trial outcomes. Key developments expected within the forecast period encompass a greater embrace of biomarker-driven trial designs, an increased application of multi-omics patient stratification, the deepening integration of real-world evidence analytics, the enlargement of precision oncology clinical trials, and an intensified focus on data-centric trial optimization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27369&type=smp

What Key Drivers Are Influencing The Growth Of The Omics-Based Clinical Trials Market?

The expanding requirement for personalized medicine is projected to fuel the expansion of the omics-based clinical trials market in the future. This medical approach involves customizing disease prevention, diagnosis, and treatment based on the unique attributes of each patient. The heightened demand for personalized medicine stems from advancements in genomic technologies, which facilitate quicker and more economical analysis of individual genetic profiles to inform specific therapies. Omics-based clinical trials bolster personalized medicine through their capacity to identify distinct genetic, proteomic, and metabolic profiles, leading to more precise and efficacious treatment plans customized for individual patients. For example, data from February 2024, provided by the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, indicated that the US Food and Drug Administration sanctioned 16 novel personalized treatments for rare disease patients in 2023. This marked an increase from six approvals in 2022, with the 2023 clearances also covering seven oncology therapies and three treatments for diverse other conditions. Consequently, the escalating need for personalized medicine is serving as a primary impetus for the expansion of the omics-based clinical trials market.

What Are The Key Segments Of The Omics-Based Clinical Trials Market?

The omics-based clinical trials market covered in this report is segmented –

1) By Type: Genomics, Proteomics, Metabolomics, Transcriptomics

2) By Phase: Phase I, Phase II, Phase III, Phase IV

3) By Study Design: Interventional Studies, Observational Studies, Expanded Access Studies

4) By Application: Oncology, Cardiovascular, Neurology, Infectious Diseases, Metabolic Disorders

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals And Diagnostic Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Proteomics: Protein Expression Profiling, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping

3) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Metabolic Flux Analysis

4) By Transcriptomics: Microarray Analysis, Single-Cell Transcriptomics, Gene Expression Profiling

How Are Trends Impacting The Omics-Based Clinical Trials Market?

Companies involved in the omics-based clinical trials market are prioritizing advanced solutions, like HiFi sequencing technology, to boost the precision, pace, and thoroughness of multi-omics data analysis, thereby enhancing trial results and individualized treatment approaches. HiFi sequencing is a next-generation sequencing (NGS) method that generates extended, highly accurate reads through circular consensus sequencing (CCS), enabling comprehensive and exact examinations of genomes, transcriptomes, and epigenomes. An illustrative example occurred in October 2024, when Pacific Biosciences of California Inc., a US-based biotechnology company, together with the Agency for Science, Technology, and Research (A*STAR), a Singapore-based research and product development agency, and Macrogen Inc., a South Korea-based biotechnology company, established a cutting-edge lab to propel genomics innovation in Singapore utilizing advanced long-read sequencing technology. This facility empowers researchers to carry out sophisticated genomic studies with improved accuracy and speed. It supports a broad array of applications, including whole genome sequencing, transcriptomics, epigenetics, and metagenomics. Furthermore, the lab encourages cooperation among international scientists and local institutions, aiming to accelerate breakthroughs in personalized medicine, rare disease diagnostics, and precision oncology. Additionally, it provides training courses and communal access to high-throughput sequencing infrastructure, fostering capacity development and innovation across the Asia-Pacific region.

Who Are The Leading Companies Operating In The Omics-Based Clinical Trials Market?

Major companies operating in the omics-based clinical trials market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., GlaxoSmithKline Plc, Eli Lilly and Company, Novo Nordisk A/S, BioNTech SE, IQVIA Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, SGS Société Générale de Surveillance SA, Eurofins Scientific SE, Syneos Health Inc., Illumina Inc., Charles River Laboratories International Inc., Parexel International Corporation, Bruker Corporation, Fulgent Genetics Inc., Signios Biosciences, BioAro Inc.

Read the full omics-based clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/omics-based-clinical-trials-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Omics-Based Clinical Trials Market?

North America was the largest region in the omics-based clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics-based clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omics-Based Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27369&type=smp

Browse Through More Reports Similar to the Global Omics-Based Clinical Trials Market 2026, By The Business Research Company

Medical And Diagnostic Laboratory Services Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Medical And Diagnostic Laboratory Services Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Lab Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/lab-supplies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795